We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-19.3%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$82.8M
AUM Growth
-$28.8M
(-26%)
Cap. Flow
-$2.79M
Cap. Flow
% of AUM
-3.37%
Top 10 Holdings %
Top 10 Hldgs %
36.35%
Holding
122
New
10
Increased
23
Reduced
52
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CareDx
CDNA
|
+$930K |
| 2 |
Gilead Sciences
GILD
|
+$732K |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$704K |
| 4 |
Alphatec Holdings
ATEC
|
+$579K |
| 5 |
Rockwell Medical
RMTI
|
+$577K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aflac
AFL
|
+$1.02M |
| 2 |
Microvision
MVIS
|
+$808K |
| 3 |
The Joint Corp
JYNT
|
+$802K |
| 4 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
+$780K |
| 5 |
ANI Pharmaceuticals
ANIP
|
+$709K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 65.87% |
| 2 | Technology | 10.8% |
| 3 | Communication Services | 7.03% |
| 4 | Industrials | 5.89% |
| 5 | Consumer Staples | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Boston Scientific
BSX
$71.3B
| $547K | 0.66% |
16,749
-5,434
| -24% | -$212K |
|
|
AVGR
52
DELISTED
Avinger, Inc. Common Stock
AVGR
| $525K | 0.63% |
4,217
+1,848
| +78% | +$391K |
|
|
BIOL
53
DELISTED
Biolase, Inc.
BIOL
| $518K | 0.63% |
552
+24
| +5% | +$37.3K |
|
|
PDCO
54
DELISTED
Patterson Companies, Inc.
PDCO
| $466K | 0.56% |
30,475
+3,000
| +11% | +$64.8K |
|
55
General Mills
GIS
$19.6B
| $376K | 0.45% |
7,125
-100
| -1% | -$5.28K |
|
56
ePlus
PLUS
$2.35B
| $376K | 0.45% |
12,000
| – | – |
|
|
STRM
57
DELISTED
Streamline Health Solutions
STRM
| $371K | 0.45% |
29,102
-938
| -3% | -$16.1K |
|
58
Donaldson
DCI
$11.4B
| $370K | 0.45% |
9,567
-83
| -0.9% | -$4.06K |
|
59
Baxter International
BAX
$14.3B
| $355K | 0.43% |
4,367
-33
| -0.8% | -$2.85K |
|
60
Fastenal
FAST
$59.3B
| $341K | 0.41% |
21,800
| – | – |
|
61
H.B. Fuller
FUL
$3.28B
| $339K | 0.41% |
12,150
| – | – |
|
62
US Bancorp
USB
$99.6B
| $307K | 0.37% |
8,917
-383
| -4% | -$18.5K |
|
63
Apple
AAPL
$4.56T
| $305K | 0.37% |
4,800
| – | – |
|
|
IIN
64
DELISTED
IntriCon Corporation
IIN
| $293K | 0.35% |
24,875
+8,550
| +52% | +$134K |
|
65
Medtronic
MDT
$111B
| $243K | 0.29% |
2,700
| – | – |
|
|
ITMR
66
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $236K | 0.29% |
+20,000
| New | +$273K |
|
67
QuickLogic
QUIK
$259M
| $226K | 0.27% |
79,445
-15,106
| -16% | -$81.4K |
|
68
Dyadic International
DYAI
$36.2M
| $221K | 0.27% |
42,500
| – | – |
|
69
NXP Semiconductors
NXPI
$60.4B
| $211K | 0.25% |
2,550
| – | – |
|
70
IZEA Worldwide
IZEA
$61.8M
| $194K | 0.23% |
242,375
| – | – |
|
|
VRAY
71
DELISTED
ViewRay, Inc.
VRAY
| $185K | 0.22% |
74,100
-4,400
| -6% | -$12.5K |
|
72
GE Aerospace
GE
$385B
| $173K | 0.21% |
4,366
| – | – |
|
73
SenesTech
SNES
$6.78M
| $169K | 0.2% |
+34
| New | +$460K |
|
74
KORU Medical Systems
KRMD
$167M
| $165K | 0.2% |
22,000
-5,000
| -19% | -$33.6K |
|
75
Asure Software
ASUR
$251M
| $155K | 0.19% |
26,000
-4,000
| -13% | -$31.1K |
|
Similar funds
BF
WT
BAM
WLG
STFP
SWM
9C
LEP
Perkins Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Perkins Capital Management held 122 positions worth $82.8M, down 26% from $112M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Perkins Capital Management withdrew a net $2.79M in Q1 2020, closing 15 positions and reducing 52 holdings. Its most notable exit was Aflac, an estimated $1.02M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 63% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Perkins Capital Management opened a new position in Gilead Sciences worth $792K.
- Perkins Capital Management's largest Q1 2020 buy was Gilead Sciences: 10,600 shares worth $792K.
- Perkins Capital Management added most to CareDx in Q1 2020, an estimated $930K increase.
- Perkins Capital Management's biggest Q1 2020 reduction was Veritone, cutting an estimated $542K.
- Perkins Capital Management fully exited Aflac in Q1 2020, selling an estimated $1.02M.
- Perkins Capital Management's ten largest holdings make up 36% of its $82.8M portfolio in Q1 2020.
- Perkins Capital Management opened 10 new positions and closed 15 in Q1 2020.
- Perkins Capital Management's portfolio value fell 26% quarter-over-quarter to $82.8M.
Based on Perkins Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.